Lawsuit Overview
An investor in ZymoGenetics, Inc. (NASDAQ:ZGEN) filed a lawsuit in State Court against members of the board of directors of Zymo Genetics alleging breaches of fiduciary duty arising out of their attempt to sell ZymoGenetics, Inc too cheaply too Bristol Myers Squibb. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duty for selling biopharm...
You must register (for free) or login to view the entire case.